Ezetimibe and Urosepsis - a phase IV clinical study of FDA data

Summary:

Urosepsis is reported as a side effect among people who take Ezetimibe (ezetimibe), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Clopidogrel, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Urosepsis when taking Ezetimibe. It is created by eHealthMe based on reports of 30,221 people who have side effects when taking Ezetimibe from the FDA, and is updated regularly.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,849 Ezetimibe users. Check the latest studies of Ezetimibe.

What is Urosepsis?

Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream) is found to be associated with 899 drugs and 918 conditions by eHealthMe. Check the latest studies of Urosepsis.

On Jul, 15, 2026

30,221 people reported to have side effects when taking Ezetimibe.
Among them, 88 people (0.29%) have Urosepsis.

Among these 88 people:

How long have people been on Ezetimibe when they have Urosepsis? *

What is the gender of people who have Urosepsis when taking Ezetimibe? *

female: 71.43 %
male: 28.57 %

What is the age of people who have Urosepsis when taking Ezetimibe? *

What are other drugs people take besides Ezetimibe? *

Clopidogrel: 43 people, 48.86%
Aspirin: 35 people, 39.77%
Ramipril: 31 people, 35.23%
Dexamethasone: 28 people, 31.82%
Herceptin: 28 people, 31.82%
Paclitaxel: 27 people, 30.68%
Tramadol Hydrochloride: 25 people, 28.41%
Chlorhexidine Gluconate: 25 people, 28.41%
Loratadine: 25 people, 28.41%
Lansoprazole: 25 people, 28.41%

What are other side effects people have besides Urosepsis? *

Urinary Tract Infection: 56 people, 63.64%
Diarrhea: 45 people, 51.14%
Tremor (trembling or shaking movements in one or more parts of your body): 45 people, 51.14%
Dyspnea (difficult or laboured breathing): 43 people, 48.86%
High Blood Pressure: 41 people, 46.59%
Palmar Erythema (reddening of the palms at the thenar and hypothenar eminences): 41 people, 46.59%
Rashes (redness): 41 people, 46.59%
Neuropathy Peripheral (surface nerve damage): 41 people, 46.59%
Fatigue (feeling of tiredness): 41 people, 46.59%
Mucosal Inflammation (infection of mucous membrane): 41 people, 46.59%

What are the existing conditions these people have? *

Breast Cancer Metastatic: 41 people, 46.59%
Urinary Tract Infection: 34 people, 38.64%
Type 2 Diabetes: 11 people, 12.50%
High Blood Pressure: 6 people, 6.82%
Mucosal Inflammation (infection of mucous membrane): 5 people, 5.68%
Diabetes: 4 people, 4.55%
Dyslipidaemia (abnormal amount of lipids): 4 people, 4.55%
Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 4.55%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 3 people, 3.41%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 2 people, 2.27%

* Approximation only. Some reports may have incomplete information.

Do you take Ezetimibe and have Urosepsis?

- Check whether Urosepsis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ezetimibe:

Ezetimibe (30,849 reports)

Urosepsis treatments and more:

Urosepsis (11,959 reports)

Browse all side effects of Ezetimibe:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urosepsis:

Urosepsis (899 drugs)

Browse all the conditions that are associated with Urosepsis:

Urosepsis (918 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ezetimibe (the active ingredients of Ezetimibe) and Ezetimibe (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.